glp-1 blindness Lawsuits claiming Ozempic, other GLP-1s led to become second mass litigation over the drugs Vision loss: GLP-1 drugs like

Molecules (2019) 24(8):1583

Zhang J-K, Zhang Z, Guo Z-A, Fu Y, Chen X-J, Chen W-J, et al

Cell Mol Life Sci 75:33133327

During treatment, your provider may monitor: IGF-1 levels glucose and insulin response cholesterol markers liver function kidney function thyroid markers sex hormones blood pressure symptom changes sleep quality energy levels appetite recovery speed body composition skin quality workout performance side effects Monitoring allows your provider to adjust the dosage, change the treatment timeline, pause therapy if needed, or switch to a better-suited peptide based on how your body responds

We used inverse-probability-of-censoring weights to address differential follow-up, and stabilized censoring weights were well behaved (few extremes), which helps explain why the confidence intervals are not excessively wide